Group One Trading, L.P. Xencor Inc Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$26.68 - $41.63 $26,680 - $41,630	-1,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$33.67 - $43.44 $33,670 - $43,440	1,000 New	1,000 $40,000
Q2 2020 Aug 13, 2020	SELL	$27.76 - $33.42 $198,095 - $238,485	-7,136 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$20.69 - $37.79 $136,016 - $248,431	6,574 Added 1169.75%	7,136 $213,000
Q4 2019 Feb 10, 2020	BUY	$32.75 - $41.43 $18,405 - $23,283	562 New	562 $19,000

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.44B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.